CAMBREX CORPORATION FOR NON-EMPLOYEE DIRECTORSRestricted Stock Unit Award Agreement • February 13th, 2019 • Cambrex Corp • Pharmaceutical preparations • Delaware
This award agreement (the “Agreement”) sets forth the terms of the award (the “Award”), described below, of Restricted Stock Units (the “RSUs”) under the Cambrex Corporation 2012 Equity Incentive Plan for Non-Employee Directors (the “Plan”) to the Participant identified below. The Award is subject to the terms of the Plan, which are incorporated herein by reference. Any initially capitalized term not defined herein shall have the meaning assigned to it in the Plan. The term “vest” as used in this Agreement with respect to any RSU means the lapsing of the restrictions described herein with respect to the right to payment under the Award.
CAMBREX CORPORATION rESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • February 13th, 2019 • Cambrex Corp • Pharmaceutical preparations • Delaware
THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”) entered into as of ___________, by and between ____________ (the “Participant”) and Cambrex Corporation, a Delaware corporation (the “Company”), evidences the grant of Restricted Stock Units (the “Award”) under the Cambrex Corporation 2009 Long-Term Incentive Plan, as amended and restated from time to time (the “Plan”). All capitalized terms not defined herein have the definitions set forth in the Plan.
AGREEMENT AND PLAN OF MERGER Among CAMBREX CORPORATION AVIATOR MERGER SUB, INC. AVISTA PHARMA SOLUTIONS, INC. THE SIGNATORY STOCKHOLDERS PARTY HERETO and AMPERSAND 2011 LIMITED PARTNERSHIP AS THE STOCKHOLDERS’ REPRESENTATIVE Dated as of November 19, 2018Agreement and Plan of Merger • February 13th, 2019 • Cambrex Corp • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (the “Agreement”) is entered into as of November 19, 2018, by and among Cambrex Corporation, a Delaware corporation (“Buyer”), Aviator Merger Sub, Inc., a Delaware corporation and wholly owned Subsidiary of Buyer (“MergerSub”), Avista Pharma Solutions, Inc., a Delaware corporation (the “Company”), the Signatory Stockholders and Ampersand 2011 Limited Partnership in its capacity as the Stockholders’ Representative. Buyer, MergerSub, the Company and each Signatory Stockholder are individually referred to herein as a “Party” and collectively referred to herein as the “Parties.”
